DMD: pharmacological trials-3

  • Italfarmaco: Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
  • Italfarmaco-E: Open label, long term safety, tolerability, and efficacy study of Givinostat in all DMD patients who have been previously treated in one of the Givinostat studies

 

Acronym

Italfarmaco

Italfarmaco-E

Study type
BMR BMR
Trial type
Multicentre trial Multicentre trial
Intervention Givinostat vs Placebo Givinostat vs Placebo
Principal investigator Odile Boespflug-Tanguy Odile Boespflug-Tanguy
Sponsor Italfarmaco Italfarmaco
Fundings Italfarmaco Italfarmaco
Study status Ongoing In preparation
Recruitment status Ongoing
Population Child Child
+ infos on clinicaltrials.gov